💊

M-min

Tablet

🧬 Metformin Hydrochloride 🏢 Sharif Pharmaceuticals Ltd.
Generic Name Metformin Hydrochloride
Manufacturer Sharif Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 3.01 (5 x 10: ৳ 150.50) Strip Price: ৳ 30.10

🔹 Indications

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Pharmacology

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Dosage & Administration

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Interaction

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Contraindications

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Side Effects

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Pregnancy & Lactation

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Precautions & Warnings

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Pediatric Usage

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

🔹 Storage Conditions

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control.
  • In adults: M-min may be used as monotherapy or in combination with other oral antidiabetic agents or with insulin.
  • In children from 10 years of age and adolescents: M-min may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure.

💡 Frequently Asked Questions

M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. In adults: M-min may be used as monotherapy or in...
M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. In adults: M-min may be used as monotherapy or in...
M-min tablet is indicated for the treatment of type 2 diabetes mellitus, particularly in overweight patients when dietary management and exercise alone does not result in adequate glycaemic control. In adults: M-min may be used as monotherapy or in...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review